2 results match your criteria: "610 University Avenue - Suite - 3-130[Affiliation]"
Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience.
World J Urol
February 2022
Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University of Toronto, 610 University Avenue - Suite - 3-130, Toronto, ON, M5G 2M9, Canada.
Purpose: Retroperitoneal lymph node dissection (RPLND) is a treatment option for men in a primary and post-chemotherapy setting. The aim of this review was to explore the published data looking at feasibility, safety and outcomes of robotic RPLND for CSI/II NSGCT but we will in particular highlight how we have approached adoption of robotic RPLND at the Princess Margaret.
Methods: A review and summary of the published data to date was performed regarding the role of robotic RPLND for stage IIA/B nonseminoma.
The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer.
Urol Clin North Am
August 2019
Division of Urology, University Health Network, 610 University Avenue - Suite 3-130, Toronto, Ontario M5G 2M9, Canada; Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address:
Retroperitoneal lymph node dissection (RPLND) is complex; however, recent advances in technology have allowed adoption of the robotic platform for highly select cases. Initial case series have shown improved cosmesis, less blood loss, and decreased length of stay compared with open RPLND. Our preference for performing robotic RPLND is via a transperitoneal approach with the patient in the supine position, thus facilitating a bilateral template dissection identical to that used in all our open procedures.
View Article and Find Full Text PDF